- Department of Neurology, Yale School of Medicine, New Haven, Connecticut, United States.
- Department of Neurology, Mayo Clinic, Rochester, Minnesota, United States.
Adeel Shakil Zubair
Department of Neurology, Mayo Clinic, Rochester, Minnesota, United States.
DOI:10.25259/SNI_88_2021Copyright: © 2021 Surgical Neurology International This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-Share Alike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
How to cite this article: Zubair AS1, Crum B2. Somatosensory evoked potentials and Hirayama disease. Surg Neurol Int 26-Apr-2021;12:190
How to cite this URL: Zubair AS1, Crum B2. Somatosensory evoked potentials and Hirayama disease. Surg Neurol Int 26-Apr-2021;12:190. Available from: https://surgicalneurologyint.com/surgicalint-articles/10753/
Hirayama disease (HD) is a rare sporadic condition which is defined by a slowly progressive, asymmetric distal amyotrophy in the upper limbs. This condition usually presents in the juvenile years and is often clinically detected by muscle weakness and atrophy in the arms. Patients can also endorse symptoms of cold paresis which is the aggravation of muscle weakness on exposure to the cold. While the etiology of HD is currently unclear, many theories exist. One theory is that there is forward displacement of the posterior wall of the lower cervical dural canal in neck flexion causing compression and flattening of the spinal cord. Given this, somatosensory evoked potentials (SSEPs) have been discussed as a potential electrophysiologic measure. A recent study by Fustes et al. presented a series of eight cases with HD for whom the SSEP test did not turn out to be an electrophysiologic marker.[
We report a series of six patients who were diagnosed with HD between 2004 and 2012. The average age of our cohort at diagnosis was 32.8, with all six being males. These patients all underwent ulnar SSEP studies which were normal, providing additional data that the SSEP test may not be an electrophysiologic marker for patients with HD.
Our studies were not done with patients in the flexed neck position. However, a study by Misra et al. found that there was no significant change in SSEPs and F-wave parameters in HD patients when their neck was flexed versus at baseline.[
Further large studies are needed to determine the utility of SSEP in this patient population. Given the variance of data published, it is also possible that there are different phenotypes of the disease which may present differently, furthering the need for large studies.
Adeel S. Zubair, MD
Brian Crum, MD
1. Fustes OH, Kay CS, Lorenzoni PJ, Dal-Prá Ducci R, Werneck LC, Scola RH. Somatosensory evoked potentials in Hirayama disease: A Brazilian study. Surg Neurol Int. 2020. 11: 464
2. Misra UK, Kalita J, Mishra VN, Kesari A, Mittal B. A clinical, magnetic resonance imaging, and survival motor neuron gene deletion study of Hirayama disease. Arch Neurol. 2005. 62: 120-3
3. Park JS, Ko JY, Park D. The reversible effect of neck flexion on the somatosensory evoked potentials in patients with Hirayama disease: A preliminary study. Neurol Sci. 2019. 40: 181-6
4. Restuccia D, Rubino M, Valeriani M, Mirabella M, Sabatelli M, Tonali P. Cervical cord dysfunction during neck flexion in Hirayama’ disease. Neurology. 2003. 60: 1980-3